4//SEC Filing
RUBINO RICHARD J 4
Accession 0001209191-19-031039
CIK 0001337553other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 5:17 PM ET
Size
6.8 KB
Accession
0001209191-19-031039
Insider Transaction Report
Form 4
RUBINO RICHARD J
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2019-05-16$40.54/sh−2,322$94,134→ 334,406 total - Award
Common Stock
2019-05-16+13,559→ 336,728 total
Footnotes (2)
- [F1]The reported transaction includes (i) 6,779 shares of common stock that vested on May 16, 2019 and (ii) 6,780 shares of common stock that will vest on May 16, 2020, subject to the reporting person's continued employment with the issuer through such date, pursuant to, in the case of each of clauses (i) and (ii), the issuer's compensation committee having determined that the requisite performance condition (the approval and launch of Rocklatan prior to September 30, 2019) has been achieved.
- [F2]Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of performance-based restricted Common Stock.
Documents
Issuer
AERIE PHARMACEUTICALS INC
CIK 0001337553
Entity typeother
Related Parties
1- filerCIK 0001252014
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 5:17 PM ET
- Size
- 6.8 KB